A Ferritin-Based Eg95 Nanoparticle Vaccine Adjuvanted with pCpG Eliciting Robust Immune Responses Against Cystic Echinococcosis in Mice Model
Our data demonstrated that the ferritin-CpG hybrid is a promising combination adjuvant to upgrade the traditional Quil-A and this combination adjuvant-based nanovaccine presents good potential as an alternative to the commercial one for practical CE control.
Authors
- Tong Wu (ORCID: https://orcid.org/0000-0001-9968-9909)
- Xizhou Zhu (ORCID: https://orcid.org/0000-0002-3646-6668)
- Yinü Li (ORCID: https://orcid.org/0000-0002-9310-8381)
- Ting Xin
- Yuting Shang (ORCID: https://orcid.org/0000-0002-1139-9438)
- Xingjian Liu (ORCID: https://orcid.org/0000-0003-4158-3655)
- Zhifang Zhang (ORCID: https://orcid.org/0000-0002-1047-2402)
- H. Jia
- Chenghao Zhou (ORCID: https://orcid.org/0000-0002-4539-1979)
- Xintao Gao (ORCID: https://orcid.org/0009-0007-1548-6815)
Institutions
- Chinese Academy of Agricultural Sciences (CN)
- Institute of Animal Sciences (CN)
- Biotechnology Research Institute (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.2147/ijn.s499938
- Citations
- 4
- Primary Topic
- Parasitic infections in humans and animals
- Type
- article
- Field-Weighted Citation Impact
- 5.89
Funders
- Chinese Academy of Agricultural Sciences
- National Key Research and Development Program of China
- Agricultural Science and Technology Innovation Program